Skip to Main Content

Veteran vaccine developer Jacqueline Miller joined Moderna in May 2020, at the height of the race to develop a Covid shot.

“The culture shock for the first four months was breathtaking,” she told an audience at a STAT event in Boston on Tuesday.


Miller, who previously was a top vaccine executive at GlaxoSmithKline, said that she had been used to a certain kind of tempo in vaccine development: Researchers would conduct a study, sit and reflect, conduct another study, and reflect on that.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.